Trypanosoma Brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model

PLoS Neglected Tropical Diseases - United States
doi 10.1371/journal.pntd.0005125
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Diverse Inhibitor Chemotypes Targeting Trypanosoma Cruzi CYP51

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2012English

De Novo Genome Assembly Shows Genome Wide Similarity Between Trypanosoma Brucei Brucei and Trypanosoma Brucei Rhodesiense

PLoS ONE
Multidisciplinary
2016English

Lipid Metabolism in Trypanosoma Brucei

Molecular and Biochemical Parasitology
ParasitologyMolecular Biology
2010English

Transport of -Aminoisobutyrate Into Trypanosoma Brucei Brucei

Microbiology
Microbiology
1984English

Efficacy of Secnidazole-Diminazene Aceturate Combination Therapy in the Late Treatment of Trypanosoma Brucei Brucei Infection in Dogs

Brazilian Journal of Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2020English

Serum Resistance-Associated Protein Blocks Lysosomal Targeting of Trypanosome Lytic Factor in Trypanosoma Brucei

Eukaryotic Cell
2006English

Biogenesis of Glycosomes of Trypanosoma Brucei: An in Vitro Model of 3-Phosphoglycerate Kinase Import.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1988English

Genetic Control of Resistance to Trypanosoma Brucei Brucei Infection in Mice

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2011English

Figure S1: Phylogenetic Reconstruction of Trypanosoma Brucei Brucei DdRPII RPB1 Model DdRpII RPB1 Protein Sequences

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy